Neuland

News at Neuland Labs

News Articles

To stay ahead of the evolving needs and demands of the pharmaceutical and biotechnology industries the contract manufacturing organizations (CMOs), need to continuously adapt new trends. Saharsh Davuluri, Joint Managing Director, sheds light on the changes in the API manufacturing and how a CMO can adapt to the changes in the article “Navigating the Shifting Landscape of Contract API Manufacturing” on the Contract Pharma website. You can read the article by clicking here

Quality is of utmost importance. Focusing on quality in every step of manufacturing, Neuland boasts of two USFDA and EU GMP-compliant manufacturing facilities. Read more about our stringent quality control in the article “No Compromise APIs” on the Pharmaceutical Manufacturing website by clicking here

 

On-Demand Webcast: Reversed-Phase Liquid Chromatography Using Surrogate (Additional) Stationary Phases

Neuland recently sponsored the above-mentioned webinar on Liquid Chromatography. You can view an executive summary of the webinar by downloading this PDF file (Adobe Acrobat required) or view the webcast in full (on-demand) by completing the registration details here.

Webinar PDF

 

CPhI  2016 – Neuland in Barcelona meant business

With the hype now behind us we can confirm that Barcelona CPHI 2016, proved to be a fantastic success for Neuland. Our hugely impressive stand witnessed a continuous stream of customers for most of the three days and was completely packed. In particular, the “100 % API Provider” campaign proved a great hit. It was quite refreshing to see that Neuland continued to be a 100% API producer while many of the competitors were showcasing mixed messages.

We responded to every opportunity enthusiastically and this event proved we put our customers at the centre of our thoughts.

Many of the 20,000 people using Fira station noticed the high impact Neuland advertisement. Customers also commented on the station advertisement as a massive awareness generator for the already well-known Neuland brand.

A lot of the customers made it to an after show event at the history museum in central Barcelona. We were treated to a wonderful display of over 2000 years of history.

A big thank you to all customers and staff who collaborated, as you may expect, with a lot of hard work and diligence to make CPHI 2016 a grand success.

Neuland-CPhI-2016

CPhI Madrid 2015 – 100% pure play record at CPhI proves a great success

Sometimes the obvious focus of your business needs reinforcing with a strong message and this was definitely the case at the CPhI.

Neuland took out a powerful advertising campaign on the illuminated signs on line 8 and at the main station next to the CPhI.

In addition, our API message was beamed out to 48k attendees in the show daily e blast.

The campaign reinforces our credentials as one of the few established main API players who focus entirely on API for clients. It is so easy to get distracted by FDF or selling direct to the market to improve margins.

Sometimes this can prove at odds with clients and partners who like to see a clear division between trade suppliers and those that inhabit the same direct marketing space.

As per usual at Neuland, we tried to make our land of opportunity different to those that love to see rows of reactors. We understand that people have equipment and they produce molecules of varying complexity. We are happy with what we can achieve for clients because we have world class peptide R&D and CMS which complements our formidable reactor capacity.

The human capital at Neuland is what makes this land of real opportunity for clients as well as for would be starters in the industry.

We are pleased to announce our 9th successful FDA audit along with winning the 2015 CMO Leadership award for Quality

FDA-&-CMO-Award-News

CPhI Paris 2014

We would like to thank everyone who came to visit us at CPhI in Paris. The show was a great success and we look forward to seeing you all again soon. Below are some photos from this years show.

Neuland-at-CPhI-Paris-2014

CMO Leadership Award

CMO Leadership Award 2013

Press Releases

Q3 FY 16 Press Release

Download PDF

Q2 FY 16 Press Release

Download PDF

Q1 FY 16 Press Release

Download PDF

Neuland Labs reports fourth quarter fiscal year 2015 financial results

Download PDF

Neuland Labs reports third quarter fiscal year 2015 financial results

Download PDF

FDA & CMO Award Press Release - 26th Jan 2015

Download PDF

Neuland Labs reports second quarter fiscal year 2015 financial results

Download PDF

Neuland Labs reports first quarter fiscal year 2015 financial results

Download PDF

Neuland Labs reports financial results for fiscal year 2014

Download PDF

Neuland Labs inaugurates new manufacturing facility constructed for its collaboration with Mitsubishi Healthcare Unit API Corporation

Download PDF

Draft letter of offer

Download PDF

Neuland Labs reports third quarter fiscal year 2014 financial results

Download PDF

Neuland Labs reports second quarter fiscal year 2014 financial results

Download PDF

Neuland Labs' track record of cGMP excellence complemented by 2013 CMO Leadership award for regulatory excellence

Download PDF

Neuland Labs reports financial results for fiscal year 2014

Download PDF

Neuland Labs - manufacturing collaboration with mitsubishi healthcare unit api corporation

Download PDF

Neuland Labs reports financial results for fiscal year 2013

Download PDF